CLSD
Price
$4.00
Change
+$0.27 (+7.24%)
Updated
Sep 26, 04:50 PM (EDT)
Capitalization
21.15M
52 days until earnings call
ZIVO
Price
$13.91
Change
+$0.91 (+7.00%)
Updated
Sep 25 closing price
Capitalization
53.09M
Interact to see
Advertisement

CLSD vs ZIVO

Header iconCLSD vs ZIVO Comparison
Open Charts CLSD vs ZIVOBanner chart's image
Clearside Biomedical
Price$4.00
Change+$0.27 (+7.24%)
Volume$2.55K
Capitalization21.15M
Zivo Bioscience
Price$13.91
Change+$0.91 (+7.00%)
Volume$110
Capitalization53.09M
CLSD vs ZIVO Comparison Chart in %
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. ZIVO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a StrongBuy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CLSD: $4.04 vs. ZIVO: $13.91)
Brand notoriety: CLSD and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSD: 25% vs. ZIVO: 9%
Market capitalization -- CLSD: $21.15M vs. ZIVO: $53.09M
CLSD [@Biotechnology] is valued at $21.15M. ZIVO’s [@Biotechnology] market capitalization is $53.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLSD and ZIVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 5 TA indicator(s) are bullish while ZIVO’s TA Score has 5 bullish TA indicator(s).

  • CLSD’s TA Score: 5 bullish, 3 bearish.
  • ZIVO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLSD is a better buy in the short-term than ZIVO.

Price Growth

CLSD (@Biotechnology) experienced а +7.45% price change this week, while ZIVO (@Biotechnology) price change was +6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CLSD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZIVO($53.1M) has a higher market cap than CLSD($21.1M). ZIVO YTD gains are higher at: -35.302 vs. CLSD (-71.930). CLSD has less debt than ZIVO: CLSD (533K) vs ZIVO (779K).
CLSDZIVOCLSD / ZIVO
Capitalization21.1M53.1M40%
EBITDAN/A-9.7M-
Gain YTD-71.930-35.302204%
P/E RatioN/AN/A-
RevenueN/A175K-
Total CashN/A9.82K-
Total Debt533K779K68%
FUNDAMENTALS RATINGS
CLSD vs ZIVO: Fundamental Ratings
CLSD
ZIVO
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9791
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
1336

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZIVO's Valuation (78) in the null industry is in the same range as CLSD (88) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's Profit vs Risk Rating (100) in the null industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's SMR Rating (100) in the null industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's Price Growth Rating (91) in the null industry is in the same range as CLSD (97) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

CLSD's P/E Growth Rating (76) in the Pharmaceuticals Major industry is in the same range as ZIVO (100) in the null industry. This means that CLSD’s stock grew similarly to ZIVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSDZIVO
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELPW0.340.01
+3.09%
Elong Power Holding Limited
WEC112.851.61
+1.45%
WEC Energy Group
KOD15.780.10
+0.67%
Kodiak Sciences
GNFT3.540.01
+0.16%
Genfit SA
VIST36.13-0.90
-2.43%
Vista Energy SAB de CV

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+7.24%
ABVX - CLSD
50%
Loosely correlated
+0.98%
IMNN - CLSD
30%
Poorly correlated
+0.39%
ANEB - CLSD
29%
Poorly correlated
-1.64%
BOLT - CLSD
29%
Poorly correlated
-2.00%
ACLX - CLSD
28%
Poorly correlated
+1.64%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
-2.18%
ATXS - ZIVO
21%
Poorly correlated
+2.10%
COGT - ZIVO
20%
Poorly correlated
+6.55%
CLSD - ZIVO
20%
Poorly correlated
+8.31%
ATHA - ZIVO
15%
Poorly correlated
+1.31%
More